<DOC>
	<DOCNO>NCT02636803</DOCNO>
	<brief_summary>The aim study provide data efficacy oxfendazole Trichuris trichiura different dos comparison standard single 400 mg dose albendazole . In addition , study provide data oxfendazole efficacy common nematode encounter man ( Enterobius vermicularis , Ascaris lumbricoides , Ancylostoma duodenalis , Necator americanus ) .</brief_summary>
	<brief_title>Study Efficacy Oxfendazole Compared Albendazole Treatment Trichuris Trichiura Infection Adults</brief_title>
	<detailed_description>This open , comparative study adult patient proven intestinal infection Trichuris trichiura . Patients meet study entry criterion receive either 6mg/kg , 30 mg/kg oxfendazole single oral dose 6 mg/kg orally three day albendazole 400mg single oral dose . Stool sample obtain examine 7 , 14 21 day treatment . Two hundred clinically evaluable patient either gender , 16 - 65 year age , present proven Trichuris trichiura infection , recruit one centre , include study . 15 patient treatment group . Duration accrual determine discussion clinical site Iquitos , Peru .</detailed_description>
	<mesh_term>Helminthiasis</mesh_term>
	<mesh_term>Oxfendazole</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<criteria>1 . Written witnessed oral inform consent obtain . 2 . Has Trichuris trichiura demonstrate stool sample obtain week enrolment : The presence helminth : Enterobius vermicularis , Ascaris lumbricoides , Necator americanus , Ancylostoma duodenalis cause exclusion . 3 . Is willing comply requirement protocol particularly provide 4 stool sample , pretreatment 7 , 14 21 day treatment . 4 . Female patient child bear potential , use establish method birth control ( surgically sterile , intrauterine contraceptive device , oral contraceptive , diaphragm combination contraceptive cream foam , condom combination contraceptive cream foam ) 1 . The patient demonstrate previous hypersensitivity reaction benzimidazole relate compound . 2 . Presence helminths without Trichuris trichiura . Note : Nontarget specie may present detail response record . 3 . The patient diarrhoeal disease would interfere evaluation stool sample . 4 . The patient receive anthelminthic 2 week prior enrolment study . 5 . The patient receive investigational drug within 30 day 5 halflives ( whichever longer ) screen visit schedule receive drug study period . 6 . The patient concomitant infection underlie disease would compromise diagnosis evaluation response study medication . 7 . The patient known history renal dysfunction ( plasma creatinine ≥ 1.5 time upper limit normal age ) hepatic dysfunction ( liver enzymes ≥ 1.5 8 . Is female pregnant , lactate plan pregnancy study , practice form contraception ( see inclusion criterion ( 4.2.5 ) . 9 . Patient unwilling unable take part study . 10 . The patient previously enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>trichuris</keyword>
	<keyword>hookworm</keyword>
	<keyword>Ascaris</keyword>
</DOC>